Search Page

1

Cite

Share

Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting.

Brocker CN, Kim D, Melia T, Karri K, Velenosi TJ, Takahashi S, Aibara D, Bonzo JA, Levi M, Waxman DJ, Gonzalez FJ. Brocker CN, et al. Among authors: velenosi tj. Nat Commun. 2020 Nov 17;11(1):5847. doi: 10.1038/s41467-020-19554-7. Nat Commun. 2020. PMID: 33203882 Free PMC article.

Cite

Share

2

Cite

Share

Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.

Velenosi TJ, Urquhart BL. Velenosi TJ, et al. Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/17425255.2014.931371. Epub 2014 Jun 24. Expert Opin Drug Metab Toxicol. 2014. PMID: 24961255 Review.

Cite

Share

3

Cite

Share

Metabolic products of the intestinal microbiome and extremes of atherosclerosis.

Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Wong RG, Urquhart BL, Dinculescu V, Ruetz KN, Velenosi TJ, Pignanelli M, Spence JD. Bogiatzi C, et al. Among authors: velenosi tj. Atherosclerosis. 2018 Jun;273:91-97. doi: 10.1016/j.atherosclerosis.2018.04.015. Epub 2018 Apr 17. Atherosclerosis. 2018. PMID: 29702430

Cite

Share

4

Cite

Share

β-Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial.

Tieu A, Velenosi TJ, Kucey AS, Weir MA, Urquhart BL. Tieu A, et al. Among authors: velenosi tj. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):604-611. doi: 10.2215/CJN.07470717. Epub 2018 Mar 8. Clin J Am Soc Nephrol. 2018. PMID: 29519953 Free PMC article. Clinical Trial.

Cite

Share

5

Cite

Share

Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.

Brocker CN, Patel DP, Velenosi TJ, Kim D, Yan T, Yue J, Li G, Krausz KW, Gonzalez FJ. Brocker CN, et al. Among authors: velenosi tj. J Lipid Res. 2018 Nov;59(11):2140-2152. doi: 10.1194/jlr.M088419. Epub 2018 Aug 29. J Lipid Res. 2018. PMID: 30158201 Free PMC article.

Cite

Share

6

Cite

Share

Moderate Renal Impairment and Toxic Metabolites Produced by the Intestinal Microbiome: Dietary Implications.

Pignanelli M, Bogiatzi C, Gloor G, Allen-Vercoe E, Reid G, Urquhart BL, Ruetz KN, Velenosi TJ, Spence JD. Pignanelli M, et al. Among authors: velenosi tj. J Ren Nutr. 2019 Jan;29(1):55-64. doi: 10.1053/j.jrn.2018.05.007. Epub 2018 Aug 9. J Ren Nutr. 2019. PMID: 30100156

Cite

Share

7

Cite

Share

Role of Farnesoid X Receptor and Bile Acids in Hepatic Tumor Development.

Takahashi S, Tanaka N, Fukami T, Xie C, Yagai T, Kim D, Velenosi TJ, Yan T, Krausz KW, Levi M, Gonzalez FJ. Takahashi S, et al. Among authors: velenosi tj. Hepatol Commun. 2018 Oct 1;2(12):1567-1582. doi: 10.1002/hep4.1263. eCollection 2018 Dec. Hepatol Commun. 2018. PMID: 30556042 Free PMC article.

Cite

Share

8

Cite

Share

Enzymatic and non-enzymatic mechanisms of dimesna metabolism.

Cutler MJ, Velenosi TJ, Bodalia A, House AA, Urquhart BL, Freeman DJ. Cutler MJ, et al. Among authors: velenosi tj. Amino Acids. 2015 Mar;47(3):511-23. doi: 10.1007/s00726-014-1882-0. Epub 2014 Dec 10. Amino Acids. 2015. PMID: 25488427

Cite

Share

9

Cite

Share

Untargeted metabolomics reveals N, N, N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function.

Velenosi TJ, Thomson BKA, Tonial NC, RaoPeters AAE, Mio MA, Lajoie GA, Garg AX, House AA, Urquhart BL. Velenosi TJ, et al. Sci Rep. 2019 May 2;9(1):6831. doi: 10.1038/s41598-019-42992-3. Sci Rep. 2019. PMID: 31048706 Free PMC article.

Cite

Share

10

Cite

Share

The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats.

Kucey AS, Velenosi TJ, Tonial NC, Tieu A, RaoPeters AAE, Urquhart BL. Kucey AS, et al. Among authors: velenosi tj. Pharmacol Res Perspect. 2019 Apr 26;7(3):e00475. doi: 10.1002/prp2.475. eCollection 2019 Jun. Pharmacol Res Perspect. 2019. PMID: 31049204 Free PMC article.

Cite

Share